n-Lorem, a nonprofit foundation, today announced the publication of an article in Nature Biotechnology (Crooke, S.T., et al. Nature Biotechnology advanced online publication, July 2023). In this publication, Dr. Crooke and colleagues describe the diagnostic odyssey for Patient 001, n-Lorem’s first nano-rare patient accepted…
Welcome to the Materials & Tools for Point-of-Care & Rapid Diagnostics Development 2023 Conference to be held in-person on-site in beautiful Laguna Hills, California. Bringing together researchers and industry participants from both academia and industry, this established event, will discuss…
HRC Fertility Center, one of the largest providers of advanced fertility treatments based in Southern California, announced the celebration of its 35th anniversary by unveiling special egg freezing packages including a package priced at $3,500. HRC’s highly competitive price points…
The End Drug Shortage Alliance, today announced recommended actions healthcare industry stakeholders should immediately take to help minimize supply chain disruptions of sterile injectable medications in the wake of the tornado that hit Pfizer’s Rocky Mount, North Carolina facility. The plant…
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported that on July 21, 2023, AgeX and Juvenescence Limited entered into an Exchange Agreement pursuant to which AgeX agreed to issue to…
Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, commends Kernel, a leader in non-invasive neuroimaging, on their publication titled “Measuring acute effects of…
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today announced that the Company is now a member of Microbiome…
The “Surgical Stapling Devices Market Size, Share & Trends Analysis Report By Product (Powered, Manual), By Type (Disposable, Reusable), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global surgical stapling…
LinKinVax, a clinical-stage biotechnology company, announced the manufacture and bottling of a GMP batch of its next generation pan-sarbecovirus vaccines, known as PanCov, designed to prevent COVID-19 and other known coronavirus diseases. This new protein-based vaccine is unique because it targets…
The “U.S. Remote Patient Monitoring Market – Industry Outlook & Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The U.S. remote patient monitoring market is expected to reach a value of $25.28 billion by 2028 from $13.4 billion in 2022, growing at a…
Nalu Medical, Inc. (“Nalu”), a Carlsbad, California-based neurostimulation company that has miniaturized neurostimulation implants for the management of chronic intractable pain for both Peripheral Nerve Stimulation (PNS) and Spinal Cord Stimulation (SCS) indications, presented significant new data from several studies…
Henry Schein One, a joint venture of Henry Schein Inc. and Internet Brands, announced today the launch of the Dentrix Ascend Application Programming Interface (API) Exchange, an information marketplace for software vendors to share their expertise with thousands of practices…